安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- CPT® Code 0340U - Proprietary Laboratory Analyses - AAPC
The Current Procedural Terminology (CPT ®) code 0340U as maintained by American Medical Association, is a medical procedural code under the range - Proprietary Laboratory Analyses
- CPT® Code 0340U - Coding Ahead
Have a question about CPT® Code 0340U? Get instant expert-level answers from CasePilot, our coding assistant
- Article - Billing and Coding: MolDX: Minimal Residual Disease Testing . . .
For patients with cancer, the UOS for this type of test is 1 Billing should occur at the start of the episode of testing Regarding the use of NGS-based MRD tests (e g , Signatera) in patients with cancer– The service may be performed once per patient per cancer diagnosis, unless there is clinical evidence of a priori change in genetic content
- Medical Policy Tumor-Informed Circulating Tumor DNA Testing for Cancer . . .
• 0340U: Oncology (pan-cancer), analysis of minimal residual disease (MRD) from plasma, with assays personalized to each patient based on prior next-generation sequencing of the patient’s tumor and germline DNA, reported as absence or presence of MRD, with disease-burden correlation, if appropriate
- MEDICAL POLICY - PROPRIETARY LABORATORY ANALYSES (PLA) CODES - BCBSM
They are alpha-numeric codes consisting of four numbers ending in a capital U They are meant to represent specific laboratory tests developed by a proprietary laboratory The PLA Code section includes Advanced Diagnostic Laboratory Tests (ADLTs) and Clinical Diagnostic Laboratory Tests (CDLTs)
- Proprietary Laboratory Analyses (PLA) (prop lab) - Medi-Cal
MAAAs are procedures that utilize multiple results derived from assays of various types, including molecular pathology assays, fluorescent in situ hybridization assays and non-nucleic acid-based assays (for example, proteins, polypeptides, lipids, carbohydrates)
- How to Code Signatera™ MRD Testing with CPT Code 0340U: A Comprehensive . . .
Learn how AI and automation are revolutionizing medical coding with CPT code 0340U for Signatera™ MRD testing Explore use-cases, billing accuracy, and compliance best practices with this specialized cancer detection test
- EVIDENCE-BASED SOLID TUMOR MINIMAL RESIDUAL DISEASE (MRD) TESTING
Minimal residual disease (MRD) analysis (0340U, 0422U, 81479) with sufficient evidence of clinical utility and validity using solid tumor tissue is considered investigational for all other indications where clinical utility and validity have not been demonstrated
|
|
|